Cancer Family
Basal Cell Neoplasm
CI-CAN-00000072Explore in graph →
Non-malignant58 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000072Explore in graph →
Clinical trials
362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03742726 | Study Assessing the Safety and Performance of Smart Matrix® | unknown | N/A | 32 | Smart Matrix LimitedOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT00535080 | Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease | no longer available | — | — | Galderma R&DINDUSTRY | 0 | Feb 18, 2021 | clinicaltrials |
| NCT04759261 | SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity | unknown | N/A | 75 | Trakya UniversityOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT04695015 | Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm | unknown | — | 100 | Peking UniversityOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT00880308 | Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors | completed | Phase 1 | 103 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 19, 2020 | clinicaltrials |
| NCT01208831 | An East Asian Study of LDE225 | completed | Phase 1 | 45 | Novartis PharmaceuticalsINDUSTRY | 3 | Dec 19, 2020 | clinicaltrials |
| NCT02580916 | Utility of the Skin Cancer Quality of Life Impact Tool(SCQOLIT) | completed | N/A | 318 | Oxford University Hospitals NHS TrustOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT02120677 | Topical Itraconazole in the Treatment of Basal Cell Carcinoma | completed | Early Phase 1 | 5 | Johns Hopkins UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT02699723 | Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer | withdrawn | Early Phase 1 | 0 | Jean Yuh TangOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT02825511 | Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma(CAC-CBC) | completed | — | 2,738 | University Hospital, BordeauxOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02371967 | A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)(ROSETT) | completed | — | 50 | Hoffmann-La RocheINDUSTRY | 1 | Oct 9, 2020 | clinicaltrials |
| NCT03331874 | RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma(RCM-1) | completed | — | 352 | Julie DawsonOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03714529 | A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma | completed | Phase 2 | 10 | Herlev and Gentofte HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04570683 | Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas | unknown | Early Phase 1 | 30 | Bispebjerg HospitalOTHER | 1 | Sep 30, 2020 | clinicaltrials |
| NCT02354261 | Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) | completed | Phase 2 | 38 | HedgePath Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 5, 2020 | clinicaltrials |
| NCT03734913 | A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors | unknown | Phase 1 | 65 | Guangdong Zhongsheng Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 22, 2020 | clinicaltrials |
| NCT02310503 | Spanish Registry of Mohs Surgery(REGESMOHS) | completed | — | 6,000 | Fundación Academia Española de DermatologíaOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT01872130 | Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins | completed | — | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT02956889 | To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma(virgilio) | terminated | Phase 2 | 14 | Istituto Clinico HumanitasOTHER | 1 | Jan 29, 2020 | clinicaltrials |
| NCT03420846 | Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping | terminated | N/A | 86 | Michelson Diagnostics Ltd.INDUSTRY | 1 | Jan 28, 2020 | clinicaltrials |
| NCT03321903 | EPR Tumor Oximetry With CE India Ink | terminated | — | 3 | Philip SchanerOTHER | 1 | Dec 19, 2019 | clinicaltrials |
| NCT00005884 | Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer | completed | Phase 3 | — | University of Wisconsin, MadisonOTHER | 0 | Dec 13, 2019 | clinicaltrials |
| NCT03610620 | Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery(FCM-P) | completed | N/A | 30 | Julie DawsonOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02623101 | Reflectance Confocal Microscopy in Basal Cell Carcinoma | completed | N/A | 288 | Radboud University Medical CenterOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT01245972 | Pilot Study of PDL to Treat BCC and SCCIS(PDLNMSC) | completed | N/A | 23 | University of California, San DiegoOTHER | 0 | Sep 16, 2019 | clinicaltrials |
| NCT02662244 | Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma | completed | N/A | 33 | University of California, San DiegoOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT01327053 | A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma(BOLT) | completed | Phase 2 | 230 | Novartis PharmaceuticalsINDUSTRY | 12 | Aug 28, 2019 | clinicaltrials |
| NCT02067104 | Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention | terminated | Phase 2 | 9 | University of ArizonaOTHER | 1 | Aug 14, 2019 | clinicaltrials |
| NCT01540695 | Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology | completed | — | 180 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 31, 2019 | clinicaltrials |
| NCT03237013 | Strategies to Promote Skin Health | completed | N/A | 219 | San Diego State UniversityOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT01367665 | STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | completed | Phase 2 | 1,232 | Hoffmann-La RocheINDUSTRY | 37 | Jun 6, 2019 | clinicaltrials |
| NCT03972748 | Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin. | unknown | N/A | 28 | Hospital de Clinicas de Porto AlegreOTHER | 1 | Jun 4, 2019 | clinicaltrials |
| NCT01700049 | Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes | completed | Phase 2 | 28 | Mayo ClinicOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT02902822 | Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo | completed | N/A | 461 | Centro Studi GisedOTHER | 1 | May 17, 2019 | clinicaltrials |
| NCT02674009 | Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)(NIELS) | completed | — | 67 | Hoffmann-La RocheINDUSTRY | 1 | May 13, 2019 | clinicaltrials |
| NCT02352428 | Skin Cancer Screening Education Study(SCSES) | unknown | N/A | 113 | Association of Dermatological Prevention, GermanyOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT02123511 | Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 2 | 34 | Mayo ClinicOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT03092830 | Molecular Characterization of Cutaneous Tumors | unknown | — | 500 | Rabin Medical CenterOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02735356 | Topical Itraconazole in Treating Patients With Basal Cell Cancer | completed | Early Phase 1 | 9 | Jean Yuh TangOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT02296970 | An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence | completed | — | 78 | University of PittsburghOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT02367547 | Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL | unknown | Phase 1 / Phase 2 | 117 | Joint Authority for Päijät-Häme Social and Health CareOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT02690948 | Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer | completed | Phase 1 / Phase 2 | 16 | Anne ChangOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT03822988 | ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS(PADAONCODERM) | unknown | — | 150 | Central Hospital, Nancy, FranceOTHER | 1 | Jan 30, 2019 | clinicaltrials |
| NCT02303041 | Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma | terminated | Phase 2 | 10 | Anne ChangOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02828111 | Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas(BCC) | completed | Phase 2 | 36 | PellePharm, Inc.INDUSTRY | 1 | Jan 8, 2019 | clinicaltrials |
| NCT01108094 | Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas | completed | Phase 2 | 29 | Stanford UniversityOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT02668614 | Early Detection of Skin Cancer With Sensor Technology | completed | N/A | 60 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 0 | Nov 6, 2018 | clinicaltrials |
| NCT02270645 | Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser(BCC) | completed | N/A | 12 | University of MiamiOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02750033 | Intraoperative Margin Assessment During Mohs Surgery | withdrawn | — | 0 | Seton Healthcare FamilyOTHER | 0 | Aug 20, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2021source: clinicaltrials